Vaccines and latex sensitivity

Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad. Consumers and health professionals are advised that, for the influenza season, natural rubber latex is present in the sheath covering the needle of trivalent influenza vaccine Fluad. While reactions to latex are rare, anyone who has a severe allergy to latex should not receive Fluad. Patients aged 65 years and over can still be safely vaccinated with the alternative trivalent influenza vaccine, Fluzone High-Dose through the NIP. The sponsor of Fluad, Seqirus, commits to update the Product Information and Consumer Medicines Information for this vaccine accordingly.

Morgan Liotta. The TGA has advised health professionals to be aware of patients with a latex allergy when administering the Fluad trivalent influenza vaccine. Available for patients aged 65 and over, the Fluad trivalent influenza vaccine has been confirmed by the Therapeutic Goods Administration TGA to contain natural rubber latex in the sheath covering the needle. Although reactions to latex are rare, the TGA advises that anyone who has a latex allergy should not receive Fluad. Patients aged 65 and over with a latex allergy can safely receive the alternative trivalent influenza vaccine, Fluzone High-Dose, also available through the National Immunisation Program NIP. Australian Chief Medical Officer Professor Brendan Murphy has recommended healthcare professionals administering the Fluad vaccine be aware of any patients with a latex allergy to avoid potential adverse outcomes.

Metrics details. Routine immunization, one of the most effective public health interventions, has effectively reduced death and morbidity due to a variety of infectious diseases. However, allergic reactions to vaccines occur very rarely and can be life threatening. Given the large numbers of vaccines administered worldwide, there is a need for an international consensus regarding the evaluation and management of allergic reactions to vaccines. Consensus was reached on a variety of topics, including: definition of immediate allergic reactions, including anaphylaxis, approaches to distinguish association from causality, approaches to patients with a history of an allergic reaction to a previous vaccine, and approaches to patients with a history of an allergic reaction to components of vaccines.

Skip to content. Learn the signs and symptoms of food allergy. There are approximately million doses of vaccines administered in the United States each year, and only 1 dose per million causes anaphylaxis, a serious medical reaction. Fatalities from vaccine-induced anaphylaxis are exceedingly rare. Kelso, M.